Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

1.

A rapid DNA hybridization assay for the evaluation of antiviral compounds against Epstein-Barr virus.

Prichard MN, Daily SL, Jefferson GM, Perry AL, Kern ER.

J Virol Methods. 2007 Sep;144(1-2):86-90. Epub 2007 May 30.

PMID:
17540461
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Real-time quantitative PCR for assessment of antiviral drug effects against Epstein-Barr virus replication and EBV late mRNA expression.

Ballout M, Germi R, Fafi-Kremer S, Guimet J, Barguès G, Seigneurin JM, Morand P.

J Virol Methods. 2007 Jul;143(1):38-44. Epub 2007 Mar 19.

PMID:
17368820
[PubMed - indexed for MEDLINE]
3.

Evaluation of antiviral activity against human herpesvirus 8 (HHV-8) and Epstein-Barr virus (EBV) by a quantitative real-time PCR assay.

Friedrichs C, Neyts J, Gaspar G, De Clercq E, Wutzler P.

Antiviral Res. 2004 Jun;62(3):121-3.

PMID:
15130535
[PubMed - indexed for MEDLINE]
4.

Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: structure-activity relationships.

Lin JC, Cherng JM, Hung MS, Baltina LA, Baltina L, Kondratenko R.

Antiviral Res. 2008 Jul;79(1):6-11. doi: 10.1016/j.antiviral.2008.01.160. Epub 2008 Mar 31.

PMID:
18423902
[PubMed - indexed for MEDLINE]
5.

Screening of drugs inhibiting Epstein-Barr virus replication.

Liu MY, Yen HK, Chern JW, Tsai CH, Yang CS, Chen JY.

Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1996 May;29(2):80-9.

PMID:
10592789
[PubMed - indexed for MEDLINE]
6.

Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification.

Yao GQ, Grill S, Egan W, Cheng YC.

Antimicrob Agents Chemother. 1993 Jul;37(7):1420-5.

PMID:
8395789
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Evaluation of Epstein-Barr virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays.

Bounaadja L, Piret J, Goyette N, Boivin G.

J Clin Microbiol. 2013 Apr;51(4):1244-6. doi: 10.1128/JCM.03234-12. Epub 2013 Jan 16.

PMID:
23325820
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpesvirus 6 DNA in blood and other clinical specimens.

Engelmann I, Petzold DR, Kosinska A, Hepkema BG, Schulz TF, Heim A.

J Med Virol. 2008 Mar;80(3):467-77. doi: 10.1002/jmv.21095. Erratum in: J Med Virol. 2008 Dec;80(12):2177. J Med Virol. 2008 Aug;80(8):1505.

PMID:
18205230
[PubMed - indexed for MEDLINE]
9.

Activity of penciclovir against Epstein-Barr virus.

Bacon TH, Boyd MR.

Antimicrob Agents Chemother. 1995 Jul;39(7):1599-602.

PMID:
7492112
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Susceptibility in vitro of Epstein-Barr Virus to myristoylated-peptide.

Ourth DD.

Peptides. 2010 Jul;31(7):1409-11. doi: 10.1016/j.peptides.2010.03.031. Epub 2010 Apr 1.

PMID:
20362634
[PubMed - indexed for MEDLINE]
11.

Detection of Epstein-Barr virus DNA in mouthwashes by hybridization.

Ambinder RF, Wingard JR, Burns WH, Hayward SD, Saral R, Perry HR, Santos GW, Hayward GS.

J Clin Microbiol. 1985 Mar;21(3):353-6.

PMID:
2984244
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

A microtiter virus yield reduction assay for the evaluation of antiviral compounds against human cytomegalovirus and herpes simplex virus.

Prichard MN, Turk SR, Coleman LA, Engelhardt SL, Shipman C Jr, Drach JC.

J Virol Methods. 1990 Apr;28(1):101-6.

PMID:
2161417
[PubMed - indexed for MEDLINE]
13.

Inhibitory effects of novel nucleoside and nucleotide analogues on Epstein-Barr virus replication.

Meerbach A, Holý A, Wutzler P, De Clercq E, Neyts J.

Antivir Chem Chemother. 1998 May;9(3):275-82.

PMID:
9875407
[PubMed - indexed for MEDLINE]
14.

The enantiomers of carbocyclic 5'-norguanosine: activity towards Epstein-Barr virus.

Rajappan V, Schneller SW, Williams SL, Kern ER.

Bioorg Med Chem. 2002 Apr;10(4):883-6.

PMID:
11836094
[PubMed - indexed for MEDLINE]
15.

A reporter system for Epstein-Barr virus (EBV) lytic replication: anti-EBV activity of the broad anti-herpesviral drug artesunate.

Auerochs S, Korn K, Marschall M.

J Virol Methods. 2011 May;173(2):334-9. doi: 10.1016/j.jviromet.2011.03.005. Epub 2011 Mar 17.

PMID:
21396962
[PubMed - indexed for MEDLINE]
16.

Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro.

Lin JC.

Antiviral Res. 2003 Jun;59(1):41-7.

PMID:
12834859
[PubMed - indexed for MEDLINE]
17.

A comparison of quantitative-competitive and realtime PCR assays using an identical target sequence to detect Epstein-Barr virus viral load in the peripheral blood.

Xu S, Green M, Kingsley L, Webber S, Rowe D.

J Virol Methods. 2006 Nov;137(2):205-12. Epub 2006 Aug 1.

PMID:
16879878
[PubMed - indexed for MEDLINE]
18.

Evaluation of varicella-zoster antiviral drugs by a nucleic acid hybridization assay.

Stanberry LR, Myers MG.

Antiviral Res. 1988 Sep;9(6):367-77.

PMID:
2852488
[PubMed - indexed for MEDLINE]
19.

Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.

Stevens SJ, Smits PH, Verkuijlen SA, Rockx DA, van Gorp EC, Mulder JW, Middeldorp JM.

AIDS. 2007 Oct 18;21(16):2141-9.

PMID:
18090040
[PubMed - indexed for MEDLINE]
20.

A rapid plate assay for the screening of inhibitors against herpesvirus DNA polymerases and processivity factors.

Lin K, Ricciardi RP.

J Virol Methods. 2000 Aug;88(2):219-25.

PMID:
10960709
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk